197 related articles for article (PubMed ID: 25846334)
1. Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.
Kuthning A; Mösker E; Süssmuth RD
Appl Microbiol Biotechnol; 2015 Aug; 99(15):6351-61. PubMed ID: 25846334
[TBL] [Abstract][Full Text] [Related]
2. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.
Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S
Chem Biol; 2011 Jan; 18(1):90-100. PubMed ID: 21276942
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering of lanthipeptides in Escherichia coli: assessing the specificity of lichenicidin and haloduracin biosynthetic machinery.
Caetano T; Barbosa J; Möesker E; Süssmuth RD; Mendo S
Res Microbiol; 2014 Sep; 165(7):600-4. PubMed ID: 25058408
[TBL] [Abstract][Full Text] [Related]
4. Lichenicidin rational site-directed mutagenesis library: A tool to generate bioengineered lantibiotics.
Barbosa J; Caetano T; Mösker E; Süssmuth R; Mendo S
Biotechnol Bioeng; 2019 Nov; 116(11):3053-3062. PubMed ID: 31350903
[TBL] [Abstract][Full Text] [Related]
5. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
6. Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection.
Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S
Appl Environ Microbiol; 2011 Jul; 77(14):5023-6. PubMed ID: 21602391
[TBL] [Abstract][Full Text] [Related]
7. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.
Oldach F; Al Toma R; Kuthning A; Caetano T; Mendo S; Budisa N; Süssmuth RD
Angew Chem Int Ed Engl; 2012 Jan; 51(2):415-8. PubMed ID: 22128014
[TBL] [Abstract][Full Text] [Related]
8. Production of phloroglucinol by Escherichia coli using a stationary-phase promoter.
Cao Y; Xian M
Biotechnol Lett; 2011 Sep; 33(9):1853-8. PubMed ID: 21544607
[TBL] [Abstract][Full Text] [Related]
9. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol.
Rodrigues AL; Becker J; de Souza Lima AO; Porto LM; Wittmann C
Biotechnol Bioeng; 2014 Nov; 111(11):2280-9. PubMed ID: 24889673
[TBL] [Abstract][Full Text] [Related]
10. Rapid Screening of Lanthipeptide Analogs via In-Colony Removal of Leader Peptides in Escherichia coli.
Si T; Tian Q; Min Y; Zhang L; Sweedler JV; van der Donk WA; Zhao H
J Am Chem Soc; 2018 Sep; 140(38):11884-11888. PubMed ID: 30183279
[TBL] [Abstract][Full Text] [Related]
11. Heterologous Expression of Mersacidin in
Viel JH; Jaarsma AH; Kuipers OP
ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311
[TBL] [Abstract][Full Text] [Related]
12. Functional Expression of GFP-Fused Class I Lanthipeptides in
Van Staden ADP; Faure LM; Vermeulen RR; Dicks LMT; Smith C
ACS Synth Biol; 2019 Oct; 8(10):2220-2227. PubMed ID: 31553571
[TBL] [Abstract][Full Text] [Related]
13. Use of the mCherry fluorescent protein to optimize the expression of class I lanthipeptides in Escherichia coli.
Van Zyl WF; Van Staden AD; Dicks LMT; Trindade M
Microb Cell Fact; 2023 Aug; 22(1):149. PubMed ID: 37559122
[TBL] [Abstract][Full Text] [Related]
14. Impact of domestication in the production of the class II lanthipeptide lichenicidin by Bacillus licheniformis I89.
Caetano T; Süssmuth RD; Mendo S
Curr Microbiol; 2015 Mar; 70(3):364-8. PubMed ID: 25399299
[TBL] [Abstract][Full Text] [Related]
15. Structure, dynamics and kinetics of two-component Lantibiotic Lichenicidin.
de Miguel A; Tapia-Rojo R; Utesch T; Mroginski MA
PLoS One; 2017; 12(6):e0179962. PubMed ID: 28654661
[TBL] [Abstract][Full Text] [Related]
16. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli.
Xu P; Vansiri A; Bhan N; Koffas MA
ACS Synth Biol; 2012 Jul; 1(7):256-66. PubMed ID: 23651248
[TBL] [Abstract][Full Text] [Related]
17. Robotic Construction and Screening of Lanthipeptide Variant Libraries in
Guo E; Fu L; Fang X; Xie W; Li K; Zhang Z; Hong Z; Si T
ACS Synth Biol; 2022 Dec; 11(12):3900-3911. PubMed ID: 36379012
[TBL] [Abstract][Full Text] [Related]
18. In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli.
Zhu F; Zhong X; Hu M; Lu L; Deng Z; Liu T
Biotechnol Bioeng; 2014 Jul; 111(7):1396-405. PubMed ID: 24473754
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of cytidine production by coexpression of gnd, zwf, and prs genes in recombinant Escherichia coli CYT15.
Fang H; Xie X; Xu Q; Zhang C; Chen N
Biotechnol Lett; 2013 Feb; 35(2):245-51. PubMed ID: 23070626
[TBL] [Abstract][Full Text] [Related]
20. Class II two-peptide lanthipeptide proteases: exploring LicTP for biotechnological applications.
Barbosa JC; Mösker E; Faria R; Süssmuth RD; Mendo S; Caetano T
Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1687-1696. PubMed ID: 36763118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
